Immune surveillance against a solid tumor fails because of immunological ignorance.
about
Tumor-specific Th17-polarized cells eradicate large established melanomaCancer immunoediting from immune surveillance to immune escapeMolecular and clinical implementations of ovarian cancer mouse avatar modelsMannose receptor (MR) engagement by mesothelin GPI anchor polarizes tumor-associated macrophages and is blocked by anti-MR human recombinant antibodyImmunosuppressive networks in the tumour environment and their therapeutic relevanceImmunosuppressive strategies that are mediated by tumor cellsSuccessful chemoimmunotherapy against hepatocellular cancer in a novel murine model.Incorporation of CD40 ligand into the envelope of pseudotyped single-cycle Simian immunodeficiency viruses enhances immunogenicity.RIPK1 and NF-κB signaling in dying cells determines cross-priming of CD8⁺ T cells.Phage display particles expressing tumor-specific antigens induce preventive and therapeutic anti-tumor immunity in murine p815 model.Systemic treatment of xenografts with vaccinia virus GLV-1h68 reveals the immunologic facet of oncolytic therapy.Distribution of immune cells in head and neck cancer: CD8+ T-cells and CD20+ B-cells in metastatic lymph nodes are associated with favourable outcome in patients with oro- and hypopharyngeal carcinomaImmunotherapy in acute leukemiaCross-presentation of tumour antigens: evaluation of threshold, duration, distribution and regulation.Get into the groove! Targeting antigens to MHC class II.Immune selection in neoplasia: towards a microevolutionary model of cancer development.Bridging innate and adaptive antitumor immunity targeting glycans.What is missing in immunology to understand immunity?Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis.Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs.Dying and necrotic neutrophils are anti-inflammatory secondary to the release of alpha-defensinsTumour immunotherapy: new tools, new treatment modalities and new T-cell antigens.Immunity against solid tumors?Viral escape mechanisms--escapology taught by viruses.Cell-based therapy approaches using dying cells: from tumour immunotherapy to transplantation tolerance induction.Tumor emergence is sensed by self-specific CD44hi memory Tregs that create a dominant tolerogenic environment for tumors in mice.Influence of tumor vaccines on graft versus tumor activity and graft versus host disease in allogeneic bone marrow transplantation.Intralymphatic immunization enhances DNA vaccination.Provision of antigen and CD137 signaling breaks immunological ignorance, promoting regression of poorly immunogenic tumors.Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses.Uncertainties - discrepancies in immunology.Chemotherapy and tumor immunity: an unexpected collaborationAntigenicity and immunogenicity of Melan-A/MART-1 derived peptides as targets for tumor reactive CTL in human melanoma.Targeting tumours with genetically enhanced T lymphocytes.Principles of tumor immunosurveillance and implications for immunotherapy.Understanding tumor heterogeneity as functional compartments--superorganisms revisited.Immunotherapy of cancer by active vaccination: does allogeneic bone marrow transplantation after non-myeloablative conditioning provide a new option?Creating therapeutic cancer vaccines: notes from the battlefieldImmunotherapy exploiting the versatility of dendritic cells.Preclinical evidence that PD1 blockade cooperates with cancer vaccine TEGVAX to elicit regression of established tumors.
P2860
Q24648032-9328E748-9820-42DC-A6F1-9044DA707186Q24655415-E9462042-559D-4E87-8771-55D6EF5AF056Q26786724-7BCDBF7D-6FB8-48CF-8086-86A0247FEA3BQ28478285-26F6A43E-1EDA-4AA0-8680-A81014922C38Q29619244-C3B6488A-ECE0-40B1-B9D5-1F3AFD8F2173Q29636247-D289FBE5-7B33-4CF3-A3CC-35D45D4F6D78Q30276134-BD6ED4FE-450A-4AB3-A8F1-3CD56783765BQ30373512-44903514-152F-445D-B08B-4DDE2F275AF9Q30679385-2D710780-58BE-48CC-8E6E-0F3DE315336EQ31045955-4F967A03-6BE0-4D64-9B4C-DB1273CC5A28Q33479314-B46EB0B0-AFB7-4D72-B7F5-715B76FEE58CQ33495735-5DAA730F-963B-4BA7-B31B-0C08DF7B600FQ33731552-12DBDAD4-2999-4C6F-933B-1E8D6DCEBFB3Q33778847-4115096F-19CD-46CB-A5D9-4D49B66EEC63Q33815384-2ED92BA2-F236-43A9-9DA1-4E520915801CQ33948688-A893356B-70D5-40B3-BB74-19A9FE9DC17BQ33960021-64D81F9E-F175-44BA-890F-CE10FFF2D9C5Q34023421-41F06C2A-A186-437C-AF11-AFDEB72B3F78Q34026088-159974D8-A880-4B40-85AD-BEC3D1B516D2Q34028370-4D2F47FF-C586-476F-A5F5-BD5146B1F1B6Q34168249-8EE89A46-9F4B-4517-A169-4F5EE9D5DFEBQ34265381-E8F8AEA8-9CF1-43F2-815B-11D4C5690148Q34273146-F97400DA-0BA8-4A95-96D1-D94DAEDB1DDAQ34434767-77496777-87EE-4E70-9B62-DCDB2FE210C1Q34560654-F1E23E86-5E3D-48CF-B8EB-D5A742322CDAQ34610483-BF77868D-E09D-464C-8D09-0B3E8D1937BDQ34632481-0393CD48-4A83-4DC7-8A44-50E3EAFD4166Q34723827-72EC3557-78E0-47C0-95BB-86914815EDBDQ34789146-431C2268-B347-4290-B535-DD761DB48BB3Q34791108-44568200-DC7A-4F4B-B3E0-A20451B57C1BQ34792441-49720913-9B7B-4B9E-B03B-CD7224812674Q34909777-850997D6-3424-4D55-82A7-4FF7DE5759CFQ35005935-7437DD7F-5D1C-421D-BE10-4F6CADB471A4Q35037678-3899F8A0-3B8D-4578-B050-DEB86087EF67Q35043113-5F5BBA3A-B806-42FC-8996-ADD3AB40DE2FQ35054645-54287823-103A-4719-8BC9-79B2EDEC41E9Q35142329-D6B46C00-171A-4A9E-88CB-CA88F8E3F4D3Q35190925-5B2DD4A5-3B47-4E56-9B50-B8365E276B6BQ35201914-465C460D-EB0E-455E-BC28-E0B12D9BCA33Q35412152-28D6A8FA-A5E8-48A7-9584-98684B624FF3
P2860
Immune surveillance against a solid tumor fails because of immunological ignorance.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune surveillance against a solid tumor fails because of immunological ignorance.
@en
Immune surveillance against a solid tumor fails because of immunological ignorance.
@nl
type
label
Immune surveillance against a solid tumor fails because of immunological ignorance.
@en
Immune surveillance against a solid tumor fails because of immunological ignorance.
@nl
prefLabel
Immune surveillance against a solid tumor fails because of immunological ignorance.
@en
Immune surveillance against a solid tumor fails because of immunological ignorance.
@nl
P2093
P2860
P356
P1476
Immune surveillance against a solid tumor fails because of immunological ignorance.
@en
P2093
Hengartner H
Klenerman P
Ochsenbein AF
Zinkernagel RM
P2860
P304
P356
10.1073/PNAS.96.5.2233
P407
P577
1999-03-01T00:00:00Z